|
How to deal with an error in selecting a VMP (wrong MAH)
|
Laure Gardey
|
|
0 |
|
Procedure Number vs Submission Number
|
Gina Pereira
|
|
2 |
|
RPI for an academic
|
Nourredine Ait Rahmoune
|
|
1 |
|
Product specific waiver
|
Zdenka Benesova
|
|
1 |
|
Fixe-dose combination, combination pack, co-administration: when are separate RPIs needed?
|
Susan Weatherall
|
|
3 |
|
Transfer of Scientific Advice
|
Costanza Vignoli
|
|
1 |
|
Procedure Tracking Number in EU M1 envelope - IRIS number
|
Sonia Ouarti
|
|
0 |
|
PIP Annual Report, how to reflect when start date of the deferred study is not yet planned
|
Nadine van Heesch
|
|
0 |
|
Acknowledgment of Day+25 PI submission
|
Chiara Santangelo
|
|
1 |
|
update substance name
|
Annabella Amatulli
|
|
1 |
|
PIP Annual Report
|
Andreas Eriksson
|
|
1 |
|
Acknowledgment of receipt of Type IA Variation from EMA IRIS.
|
Esmail Samiwala
|
|
0 |
|
Question related to the VNees format in IRIS
|
David Holguin
|
|
1 |
|
Lead MAH in PSUSA procedure
|
Linda Garner
|
|
0 |
|
QPPV access clarification
|
Linda Garner
|
|
0 |
|
PIP modification to remove Studies
|
Angela Pizzatti
|
|
3 |
|
IRIS Roles from Multiple Organizations
|
Brian Caselli
|
|
1 |
|
PIP waiver application
|
Helen Crowley
|
|
1 |
|
General questions about IRIS
|
David Holguin
|
|
1 |
|
IRIS Marketing Status Reporting for UK Northern Ireland - Windsor Framework
|
Roberta Bernardelli
|
|
1 |